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Abstract
Omega-3-fatty acid DHA is a structural component of brain plasma membranes, thereby crucial for neuronal signaling;
however, the brain is inefficient at synthesizing DHA. We have asked how levels of dietary n-3 fatty acids during brain
growth would affect brain function and plasticity during adult life. Pregnant rats and their male offspring were fed an n-3
adequate diet or n-3 deficient diets for 15 weeks. Results showed that the n-3 deficiency increased parameters of anxiety-
like behavior using open field and elevated plus maze tests in the male offspring. Behavioral changes were accompanied by
a level reduction in the anxiolytic-related neuropeptide Y-1 receptor, and an increase in the anxiogenic-related
glucocorticoid receptor in the cognitive related frontal cortex, hypothalamus and hippocampus. The n-3 deficiency reduced
brain levels of docosahexaenoic acid (DHA) and increased the ratio n-6/n-3 assessed by gas chromatography. The n-3
deficiency reduced the levels of BDNF and signaling through the BDNF receptor TrkB, in proportion to brain DHA levels, and
reduced the activation of the BDNF-related signaling molecule CREB in selected brain regions. The n-3 deficiency also
disrupted the insulin signaling pathways as evidenced by changes in insulin receptor (IR) and insulin receptor substrate
(IRS). DHA deficiency during brain maturation reduces plasticity and compromises brain function in adulthood. Adequate
levels of dietary DHA seem crucial for building long-term neuronal resilience for optimal brain performance and aiding in
the battle against neurological disorders.
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Introduction
The causes of most neurological disorders are indefinite and
characterized by multiple components, in which the interaction of
the environment with the genome likely plays a major role. Dietary
factors are garnering special recognition as important modifiers of
brain function and plasticity, and mental heath [1]. Anxiety and
depression disorders have no clear causes and are commonly
encountered in industrialized societies, posing high health care and
economicburdens.Inadditiontoaffectingindividualsatallstagesof
life, an alarmingly increasing number of young adults suffer from
anxiety disorders [2] making it imperative to develop therapeutic
strategies to moderate the incidence of mood disorders. New studies
emphasize the quality of the diet as an important factor affecting the
occurrence of mood disorders in a large population of adults [3];
however, poor knowledge on the molecular mechanisms involved
has delayed the implementation of diet as a strategy for the
prevention or treatment of mood disorders.
The capacity of the n-3-fatty acid docosahexaenoic acid (DHA;
22:6n-3) to promote brain plasticity and cognitive function is
starting to be recognized [4]. DHA is an important component of
neural membranes that accumulates rapidly in tissue during
infancy [5]. Neither brain nor body can synthesize DHA by itself
and it must be obtained from diet [6]. During prenatal de-
velopment, DHA is delivered to the brain by maternal source via
uteroplacental circulation [7], emphasizing the importance of
maternal supply of n-3 fatty acids for the neurological function of
the offspring. In turn, n-6 fatty acids generally compete with n-3
fatty acids for membrane occupancy such that the reciprocal
relationship between n-3 and n-6 fatty acids is altered in DHA
deficient conditions, imposing a risk for neuronal function [8,9].
Brain-derived neurotrophic factor (BDNF) is important for
brain function and plasticity throughout lifespan. It exerts its
biological function through binding to its receptor TrkB, which
initiates multiple signaling cascades [10]. Dysfunction in BDNF
signaling may be implicated in the pathophysiology of anxiety and
depression [11,12,13]. The action of BDNF has been linked to
molecules important for the control of brain energy metabolism
and anxiety-like behaviors such as neuropeptide Y (NPY) and
glucocorticoid receptor (GR) [14].
Dietary factors are intrinsically related to metabolism, and new
evidence emphasizes the potential link between brain metabolism
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prevalent during brain development, modulating the risk for psy-
chiatric disorders in adulthood [16,17]. Therefore, it is important to
understand how metabolic elements such as the insulin system can
affect the substrates of mental function. The current study suggests
the interesting possibility of diet as a modulator of brain metabolism
and behavioral plasticity and mayshed light on a new, non-invasive,
and cost-effective therapeutic solution for mental illnesses.
Results
Effects of n-3 fatty acid dietary manipulation on
Anxiety-like behavior
The open field (OF) and elevated plus maze (EPM) studies were
performed to assess anxiety-like behavior. Omega-3 def rats showed
a significantly decreased number of center entries as compared to n-
3 diet group (t10=2.222, p=0.0433) as shown in Fig. 1A. The time
spentat the centerofthearena was significantly decreased inn-3def
rats as compared to n-3 diet rats as shown in Fig. 1B (t10=2.398,
p=0.0310). To further confirm the anxiogenic effects of n-3 def diet
we performed the elevated plus maze test. In fig. 1C, the n-3 def
group significantly decreased the time spent in open arms as
compared to the n-3 diet group (t10=2.346, p=0.0342).
Effects of n-3 deficiency on the levels of fatty acids in
brain
Toassess the effects of n-3 deficient diet,wemeasuredthe levelsof
various fattyacidsinbrain byusing gas chromatography asshown in
Table 1. We found a significant decrease in the levels of DHA in the
animal group fed on n-3 deficient diet as compared to the n-3 fed
diet counterpart (t10 =4 . 8 8 4 ,p= 0.0006) (Table 1. C22:6n-3;
Fig. 2A). The ratio of the n-6 fatty acid arachidonic acid (AA) versus
n-3 fattyacidDHA (AA/DHA)was significantlyincreased inthe n-3
deficient animals as compared to n-3 diet animals (t10=10.33,
p,0.0001) (Table 1. C18:2n-6/C22:6n-3, Fig. 2B).
Effects of n-3 deficiency on molecules associated with
anxiety-like behavior
The anxiety-reducing effects of NPY and the anxiety-enhancing
effects of antagonists of NPY receptors are fairly well-documented,
providing strong evidence for NPY’s role in modulating anxiety
responses. We checked the modulating effects of n-3 deficient diet
and n-3 diet on the levels of NPY1 receptor in specific brain
regions. We found a significant decrease in frontal cortex
(t10=2.957, p=0.0144), hypothalamus (t10=4.362, p=0.0014)
and hippocampus (t10=2.608, p=0.0261), when rats were fed an
Figure 1. Effect of dietary n-3 fatty acid deficiency on anxiety-like behavior. Open field showed a decrease in number of center entries
(p,0.05) (A) and center time (p,0.05) (B) in n-3 deficient group compared to n-3 diet group. (C) EPM showed a decrease in time spent in open arm in
n-3 deficient as compared to n-3 diet. Values are expressed in mean 6SEM. *p,0.05 Vs n-3 diet.
doi:10.1371/journal.pone.0028451.g001
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early dietary events induced persistent modifications in the levels
of glucocorticoid receptor (GR), a molecule that responds to stress
related situations. We found that the n-3 deficient group showed
increased percentage levels of GR in the frontal cortex (t10=2.415,
p=0.0364), hypothalamus (t10=2.494, p=0.0317) and hippocam-
pus (t10=2.326, p=0.0424), as compared to the n-3 diet
counterpart (Fig. 3B).
Effects of n-3-deficiency on molecules associated with
synaptic plasticity
Inratsfedn-3deficientdiets,resultsshowed a significantdecrease
on the levels of BDNF in the hypothalamus (t10=2.758, p=0.0202)
and hippocampus (t10=2.273, p=0.0463) when compared to n-3
diet. In the frontal cortex (t10=0.6751, p=0.5149), we observed no
significant change between diets (Fig. 4A).
Previous studies have shown that young mice lacking functional
full-length TrkB exhibited a markedly enhanced anxiety-like
behavior as evidenced by their decreased explorative activity in
the open field and elevated plus maze tests [20]. In our study, we
observed a significant decrease in frontal cortex (t10=3.002,
p=0.0133), hypothalamus (t10=4.377, p=0.0014) and hippocam-
pus (t10=2.946, p=0.0146) on the levels of phosphorylated TrkB
in n-3 deficient group in all three regions respectively (Fig. 4B).
BDNF/TrkB-mediated signaling involve the MAP kinase and
PI-3 kinase pathways leading to activation of cyclic AMP response
element binding protein (CREB), which has been reported to be a
key mediator of cell survival via initiation of transcription [21]. We
assessed levels of phospo-CREB (pCREB) to further elucidate the
effects of omega-3-fatty acid deficiency on BDNF signaling. We
found that levels of pCREB significantly decreased in the
hypothalamus (t10=2.406, p=0.0369) and in the hippocampus
(t10=2.563, p=0.0282), while no significant changes were
observed in the frontal cortex (t10=2.022, p=0.0707) of rats fed
an n-3 deficient diet as compared to n-3 diet rats (Fig. 4C).
Association between levels of DHA and pTrkB receptor
Given the importance of dietary n-3 fatty acid on BDNF signaling,
we have correlated the levels of DHA to the levels of activated TrkB
in the three brain regions. We found a positive correlation between
the levels of DHA to the activated TrkB in frontal cortex (r=0.7422,
p=0.0057; Fig 5A), hypothalamus (r=0.59, p=0.0434; Fig. 5B) as
well as hippocampus (r=0.6397, p=0.0251; Fig. 5C).
Molecules related to metabolic dysfunction
Additionally, we have assessed a possible link between
metabolic regulators and mood disorders. We selected the
molecules insulin receptor (IR) and insulin receptor substrate-1
(IRS-1) for their potential role in metabolic disorders affecting
mental function. We showed that an n-3 deficient diet
differentially regulates the levels of insulin receptor in the three
studied brain regions. A significant increase was observed in
hypothalamus (t10=4.806, p=0.0007) and and hippocampus
(t10=4.068,p=0.0023); on the contrary, a decreasing trend was
observed in the frontal cortex (t10=1.3,p=0.2229) (Fig. 6A). We
Figure 2. Effect of dietary n-3 fatty acid deficiency on DHA and AA levels in brain. (A) A significant decrease (p,0.01) in the levels of DHA
in brain in n-3 deficient fed animals as compared to n-3 diet animals. (B) An increase (p,0.01) in the ratio of arachidonic acid (AA) to docosahexenoic
acid (DHA) in n-3 deficient animal group as compared to n-3 diet. Values are expressed in mean 6SEM. **p,0.01 Vs n-3 diet.
doi:10.1371/journal.pone.0028451.g002
Table 1. Fatty acid composition in brain tissue.
Fatty acid n-3 diet n-3 deficient
C14:0 0.2460.03 0.2760.021
C16:0 18.6160.73 20.2661.03
C16:1 0.5260.10 0.9360.44
C18:0 19.5960.65 20.3460.95
C18:1 14.8660.52 14.4660.58
C18:2n-6 0.6460.10 0.6560.06
C20:0 0.5760.14 0.4960.01
C20:1 1.3660.14 1.8360.69
C20:2 0.5160.13 0.3460.05
C20:3n-6 0.7560.10 0.5160.09
C20:4n-6 8.6860.29 9.9660.59
C22:4n-6 5.7062.41 4.6761.53
C24:0 0.8260.10 1.1260.06
C22:6n-3 14.8160.62 10.7060.46a
C18:2n-6/C22:6n-3 0.5860.01 0.9360.03a
Each parameter is presented as the percentage mean relative to total fatty acids
(6 SEM). Statistically significant changes are represented
ap,0.01 compared
with n-3 diet. Data were analyzed by using two-tailed unpaired t-test.
doi:10.1371/journal.pone.0028451.t001
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PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28451Figure 3. Effects of n-3-fatty acid dietary deficiency on proteins related to anxiety-like behavior. The n-3 deficient diet significantly
decreased protein levels of Neuropeptide Y (NPY) 1 receptor (A), and increased glucocorticoid receptor (GR) (B), in frontal cortex, hypothalamus, and
hippocampus. Values are expressed in mean 6SEM. *p,0.05, **p,0.01Vs n-3 diet.
doi:10.1371/journal.pone.0028451.g003
Figure 4. Effects of n-3-fatty acid dietary deficiency on proteins related to synaptic plasticity. (A) BDNF levels were significantly
decreased in the hypothalamus and the hippocampus in n-3 deficient animals compare to n-3 diet animals (p,0.05). (B) Phospho-TrkB (pTrkB) levels
showed significant decrease in frontal cortex (p,0.05), hypothalamus (p,0.01) and hippocampus (p,0.05) in n-3 deficient group compare to n-3
diet group. (C) pCREB levels were decreased in hypothalamus (p,0.05) and hippocampus (p,0.05) but not in front cortex in n-3 deficient rats
compare to n-3 diet rats. (D) Representative western blot bands are shown for BDNF, pTrkB, TrkB, pCREB, CREB and actin in three different brain
regions. Values are expressed in mean 6SEM. *p,0.05, **p,0.01 Vs n-3 diet.
doi:10.1371/journal.pone.0028451.g004
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frontal cortex (t10=7.375, p ,0.001), hypothalamus (t10=3.024,
p=0.0128) and hippocampus (t10=3.488, p=0.0058) in the
activation of IRS-1 (Fig. 6B).
Discussion
The purpose of the present study is to understand how dietary
n-3 fatty acids consumed during early development can influence
the brain’s capacity to endure challenges during adulthood. A
rapid accretion of the polyunsaturated fatty acid DHA has been
reported to occur during prenatal development in humans and
rats [22]. In turn, our results indicate that the consumption of a
diet deficient in DHA during gestation, lactation, and infancy
increases the risk for anxiety-like behavior during adulthood, and
suggest potential molecular mechanisms involved. BDNF signaling
through its receptor TrkB changed proportionally to levels of brain
DHA, such that animals with the lowest DHA showed the least
Figure 5. A significant positive correlation was observed between brain DHA levels and levels of pTrkB receptor in (A) frontal
cortex (r=0.74, p,0.01), (B) hypothalamus (r=0.59, p,0.05), and (C) hippocampus (r=0.63, p,0.05).
doi:10.1371/journal.pone.0028451.g005
Figure 6. Effects of n-3-fatty acid dietary deficiency on protein levels of (A) insulin receptor, the hypothalamus and in hippocampus
showed significant increases as compared to n-3 diet animals (p,0.01). (B) Phospho-insulin substrate receptor-1 (pIRS-1) showed significant
decrease in frontal cortex (p,0.01), hypothalamus (p,0.05) and hippocampus (p,0.01) as compared to n-3 diet animals. Values are expressed in
mean 6SEM. *p,0.05, **p,0.01 Vs n-3 diet.
doi:10.1371/journal.pone.0028451.g006
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Given the importance of n-3 fatty in membrane fluidity, it is likely
that lowered levels of DHA may have contributed to the reduction
of TrkB signaling. In addition, the DHA deficient diet reduced
markers of BDNF-related synaptic plasticity in the frontal cortex,
hippocampus and hypothalamus. The DHA deficiency also
resulted in altered levels of insulin receptor, which are important
for maintaining metabolic homeostasis and cognition. These data
emphasize the importance of DHA consumption during early
development, which can determine the potential for plasticity and
mental health during adulthood.
Molecular mechanisms: DHA levels correlate with BDNF
receptor signaling
A deficit of n-3 fatty acid significantly reduced the levels of
BDNF in the hypothalamus and hippocampus of adult rats.
Disruption in BDNF function has been implicated in the
pathophysiology of psychiatric disorders such as depression
[23,24,25], and most treatments against anxiety are associated
with the action of BDNF and its receptor [26]. In our results, the
level of activated TrkB positively correlated to brain DHA
contents for all three studied brain regions, and the n-3 deficient
diet reduced the activation of TrkB receptor. These results hold
well with previous findings that mice lacking functional TrkB
signaling, specifically in newborn neuronal populations, exhibit a
markedly enhanced anxiety-like behavior as adults [27]. Further-
more, a recent study showed that an 11 base pair deletion in the
TrkB promoter could promote anxiety related traits in human
[28]. Furthermore, given that DHA is a structural component of
the plasma membrane, reductions in DHA can have a direct
influence in the function of the membrane. Disruptions in
membrane fluidity can lower performance of transmembrane
receptors, such as reducing signaling through TrkB. The increase
in the ratio n-6/n-3 observed in our results might be indicative for
a replacement of DHA by the n-6 arachidonic acid in the
membrane, and our results showed that this ratio increase was
associated with a reduction in TrkB signaling. As discussed below,
DHA deficiency also affected levels of the insulin receptors and
related signaling IRS-1, which may also relate to changes in the
membrane fluidity.
In our studies, there was a reduction in the activation of CREB
with the n-3 deficient diet in the hypothalamus and hippocampus.
It has been shown that decreases in CREB phosphorylation and
NPY expression in the central amygdala might be associated with
anxiety-like behaviors in models of ethanol withdrawal in rats [29].
BDNF binding to its TrkB receptor leads to phosphorylation of
TrkB and downstream proteins such as the transcription factor
cyclic AMP-dependent response element binding protein (CREB).
In turn, CREB regulates the expression of many genes, including
BDNF [30,31] and NPY-1 [32].
There were no significant changes in phosphorylation of CREB
and BDNF levels in the frontal cortex, and these results differ from
a previous study’s results [33]. This apparent discrepancy might be
due to the varying rat strain, methods used to measure the levels of
BDNF, or regional differences. Accordingly, there could be
differential vulnerability of different brain regions to the n-3
deficiency at the level of transcription factor CREB activation.
CREB function is associated with the expression of BDNF as
CREB phosphorylation is required to transcribe CREB-regulated
genes including BDNF [31]. Despite the lack of net BDNF
changes, there was a significant reduction in activated TrkB levels
in the frontal cortex of rats fed the n-3 fatty acid deficient diet,
suggesting that the n-3 deficiency during brain development could
downregulate TrkB activity through BDNF-independent events. A
recent study has shown that addition of zinc to cortical neurons
cultured from mice carrying a null mutation of BDNF resulted in
increased activation of TrkB similar to that of wild type controls,
suggesting the activation of TrkB in the absence of BDNF [34].
Anxiety-like behavior and metabolism
We assessed levels of NPY-1R based on its action providing
resilience against anxiety and depression-like behavior [35],
particularly throughout the frontal cortex and limbic regions
[36]. Therefore, it is significant that early n-3 dietary manipulation
affected NPY-R in the frontal cortex, hypothalamus and
hippocampus in conjunction with the increase in anxiety-like
behavior. The human orbitofrontal cortex receives reciprocal
connections from the hippocampus, nucleus accumbens, and
hypothalamus [37] and is thought to play a significant role in
hedonic and emotional processes implicated in psychiatric
disorders. The frontal cortex, together with hippocampus,
amygdala and hypothalamus, are limbic regions forming part of
well-defined anxiety and fear-related circuits in the forebrain [38].
Given that anxiety plays an important role in altering stress related
behaviors; we evaluated the protein levels of glucocorticoid
receptor as a marker for enhanced stress. We found increased
levels of the GR reported in the three brain regions when animals
were on n-3 deficient diet. Taken together, the decrease in NPY-
1R and increase in GR in n-3 deficient rats may suggest that early
DHA deficiency can hinder the ability to cope with challenges in
adulthood, leading to anxiety-like behavior. An increasing line of
evidence indicates that anxiety and stress are coupled with
metabolic disturbances [1]. For example, in addition to anxiety
and stress, NPY and GR have been involved in regulation of
energy balance and appetite. Therefore, changes in NPY-1R and
GR by the DHA deficient diet may also have implications for
mechanisms that control food intake.
A potential metabolic pathway to cognition
We found that n-3 dietary deficiency exerted differential effects
on molecular systems vital for the regulation of metabolic disorders
that compromise cognitive abilities. For example, a DHA deficient
diet influenced the insulin signaling system as evidenced by
increases in insulin receptor (IR) levels in the hippocampus and
hypothalamus, and by reductions in phosphorylation of IR
substrate (IRS)-1 in all three regions. Insulin resistance is a
concept generally used to describe reduced insulin signaling in
spite of high levels of insulin in the body. Our results seem to
suggest that the lack of dietary n-3-fatty acids may predispose the
brain to insulin resistance and may be considered a risk factor for
diabetes. These studies emphasize how the maternal diet can
program offspring growth and metabolic pathways, which can
further alter lifelong susceptibility to metabolic disorders.
Conclusions
The results are significant to understand how dietary n-3 fatty
acids during brain growth can influence the brain’s capacity to
sustain challenges during adult life. Manipulations of the early
environment can affect the expression of neurotrophins both
during development and adulthood [39,40,41]. In our study, the
contents of the DHA in the diet influenced markers of synaptic
plasticity and energy metabolism in the frontal cortex, hippocam-
pus, and hypothalamus. More dramatically, DHA contents were
associated with levels of the BDNF signaling receptor TrkB in the
different brain regions. Our results seem to illustrate a potential
mechanism by which the consumption of DHA in infancy can help
counteract the risk for anxiety-like behavior during adulthood
(Fig. 7). The concept of ‘‘cognitive reserve’’ is generally used to
DHA and Cognitive Reserve
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challenges; however, its bases are poorly understood. The results
showing that the absence of an adequate diet during brain
formation has profound consequences for adult brain plasticity are
instrumental to better understand the neural basis for building
cognitive reserve.
Materials and Methods
Experimental designs and tissue preparation
Female Sprague–Dawley rats were obtained on the 2nd day of
pregnancy from Charles River (Portage, MI) weighing between
280 and 300 g. Animals were housed in cages and maintained in
environmentally controlled rooms (22–24uC) with a 12-h light/
dark cycle. They were divided into two dietary groups on a
pseudorandom basis with the constraint that the two groups had
the same mean body weight. One group of pregnant females was
fed an n-3 fatty acid adequate diet and a second group was fed an
n-3 fatty acid deficient diet, which are abbreviated as n-3 diet and
n-3 def respectively throughout the study. Rats were maintained
on these diets through gestation and lactation, and their male
offspring were weaned to the same diet as their dams and
maintained for 15 weeks. The two custom diets used were based
on the composition of the American Institute of Nutrition diet and
prepared commercially (Dyets, Bethlehem, PA) as previously
described [18]. Both diets had the same basal macronutrients,
vitamins, minerals, and basal fats (hydrogenated coconut and
safflower oils). The only difference between the n-3 diet and n-3
def was the amount of n-3 fatty acids, which was achieved by
adding 0.5% of flaxseed oil and 1.2% of docosahexaenoic acid
(Nordic Naturals, Inc. Watsonville, CA, USA) to the n-3 diet to
supply n-3 fatty acids (Table S1).
At the end of 15 weeks, the male offspring rats were subjected to
open field and elevated plus maze tests to assess the anxiety-like
behavior. A day after the behavioral tests, animals were killed by
decapitation and the fresh tissues, including the frontal cortex,
hypothalamus and hippocampus, were dissected, frozen in dry ice
and stored at 270uC until use for biochemical analyses.
Experiments were performed in accordance with the United
States National Institutes of Health Guide for the Care and Use of
Laboratory Animals, and were approved by the University of
California at Los Angeles Chancellor’s Animal Research Com-
mittee (ID: ARC 2001-164). The suffering and number of animals
used were minimized.
Behavioral Analyses
Open Field. The open field consisted of a 1.2 m diameter
circular tank with 60 cm walls. An inner circle, 80 cm in diameter,
was marked on the tank floor to serve as a central arena. Testing
began when each rat was placed in the middle of the central arena
and allowed to explore the field for 10 min. Rat behavior was
recorded by an overhead camera. Measurement included time
spent and number of entries in central arena using Smart tracking
software (San Diego instruments, San Diego, CA).
Elevated plus maze. The elevated plus maze (EPM) test was
carried out according to the Walf and Frye protocol [19]. The
EPM apparatus made of laminated wood and consisted of 2
opposing open arms (10650 cm) and 2 opposing closed arms
(10650 cm with 30 cm high walls). The maze was placed 60 cm
above the floor. White curtains surrounded the maze and behavior
was recorded by an overhead video camera. Each rat was placed
in the middle of the maze facing the open arm that faced away
from the experimenter. The video camera recorded the time each
rat spent in each of the arms over a period of 5 min. A closed arm
entry was counted when the rat placed all four paws in a closed
arm. An open arm entry was recorded when the rat placed all four
paws in an open arm or when the rat’s hind-limbs were placed in
the central area of the maze and both fore-limbs in an open arm
with its head protruding into the open arm.
Protein analyses
Frontal cortex, hypothalamic and hippocampal tissues were
homogenized in a lysis buffer using published protocol [14]. Levels
of brain-derived neurotrophic factor (BDNF), Glucocorticoid
receptor (GR), Neuropeptide Y-1 receptor (NPY-1R), Phopho-
tropomyosin related kinase receptor type B (pTrkB), phopho-cyclic
AMP-response element binding protein (pCREB), insulin receptor
(IR-), phospho-insulin receptor substrate 1 (pIRS-1) were analyzed
by Western blot. Protein samples were separated by electropho-
resis on a 10% (12.5% for BDNF) polyacrylamide gel and
electrotransferred to a PVDF or nitrocellulose membrane (Milli-
pore, Bedford, MA). Non-specific binding sites were blocked with
5% non-fat dry milk in Tris-buffered saline (TBS) buffer
containing 0.05% Tween-20 or 2% BSA in TBST. Membranes
were rinsed in buffer (0.05% Tween-20 in TBS) and then
Figure 7. Schematic representation for potential pathways by
which n-3 dietary deficiency may enhance vulnerability to
cognitive and mood disorders. Reductions in plasma membrane
DHA may disrupt signaling of membrane embedded receptors, such as
the BDNF receptor TrkB (Fig. 4B) and the insulin receptor (IR; Fig. 6A).
Dysfunction in TrkB signaling may influence downstream BDNF
cascades such as CaMKII and CREB (Fig. 4C), leading to further
dysfunction in the BDNF system, and ultimately increasing vulnerability
for anxiety-like behavior. Given the interaction between foods, BDNF,
synaptic plasticity, and metabolic pathways, the n-3 dietary deficiency
may disrupt events related to the insulin receptor (IR) signaling
pathways elements such as the IR substrate IRS-1, Akt and mTOR (Fig.
6B), which in turn, can affect BDNF-related synaptic plasticity leading to
increased anxiety-behavior. Our results show that metabolic and
behavioral pathways are both impacted by DHA deficiency.
doi:10.1371/journal.pone.0028451.g007
DHA and Cognitive Reserve
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28451incubated with anti-actin or anti-BDNF, anti-GR, anti-pTrkB,
anti-TrkB, anti-IR-b, anti-pIRS-1 (Tyr 989), IRS-1 (1:500; Santa
Cruz Biotechnology, Santa Cruz, CA, USA), anti-pCREB(Ser133)
and anti-CREB (1:1000; Millipore, Bedford, MA), anti-NPY-1R
(1:500; Alpha Diagnostics International Inc. San Antonio, Texas)
followed by anti-rabbit or anti goat or anti-mouse IgG horseradish
peroxidase-conjugate (1:10,000; Santa Cruz Biotechnology). The
immunocomplexes were visualized by chemiluminescence using
the ECL plus kit (Amersham Pharmacia Biotech Inc., Piscataway
NJ, USA) for GR, NPY1R, pTrkB, pCREB, IR-b, pIRS-1, IRS-1
and SuperSignal West Femto kit (Thermo Scientific, Rockford, IL)
for BDNF. Respective protein sizes were compared by using
Bench mark pre-stained protein ladder (Invitogen Technology,
Carlsbad, CA). The film signals were digitally scanned and then
quantified using ImageJ software. Actin was used as an internal
control.
Fatty acid analysis by gas chromatography
Fatty acid profiles were determined by gas chromatography in
whole cerebral cortical tissue-extracted lipids. The system
consisted of model 5890A gas chromatograph (Hewlett Packard)
and a model 7673A automatic, sampler and controller (Hewlett
Packard). An Omegawax 250 column (30 m, 0.25-mm internal
diameter, 0.25mm film thickness; Sigma-aldrich) was used, with
helium as the carrier gas. GC oven temperature was initially held
at 50uC for 2 min and raised with a gradient of 2uC min-1until
220uC and held for 30 min. The injector and detector were
maintained at 250uC and 260uC, respectively. Tissues were
reduced to powder under liquid nitrogen and subjected to
extraction of total lipids. Fatty acid methylation was achieved by
heating at 100uC for 1 hr with 14% boron tri-fluoride–methanol
reagent. A 1 m l sample of Fatty acid methyl esters (FAME) was
injected in split injection mode with a 100:1 split ratio. Peaks of
resolved fatty acid methyl esters were identified and quantified by
comparison with standards (Supelco 37-component FAME Mix).
Identification of tissue fatty acids was carried out by comparison
with the retention times of a standard mixture of fatty acid (682;
MU-Chek-Prep, Elysian, MN). An internal standard (C23:0 Me,
tricosanoic acid methylester, 50–250 ug) was added to the sample
(depending on the tissue size) before lipid extraction for the
concentration of each fatty acid determination.
Statistical analysis
Data were analyzed using statistics software (graph pad 5) and
presented as means with their standard errors (SEM). Unpaired
two-tailed t test was applied to compare the n-3 diet (n=7) and n-3
def (n=5) groups, in terms of protein and behavioral data. Protein
results are expressed as mean percent of n-3 diet. The correlations
between DHA levels and protein levels were analyzed by linear
regression analysis. Criterion for significance was set to p,0.05 in
all comparisons.
Supporting Information
Table S1 Composition of experimental diets.
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